The Medicines and Healthcare products Regulatory Agency (MHRA) has announced that it is trialling a pioneering technique for growing stem cells that could dramatically boost their supply to enable ...

We owe a lot to tissue resident memory T cells (T RM). These specialized immune cells are among the body's first responders to disease. Subscribe to our newsletter for the latest sci-tech news updates ...

Cell therapies are already here, with treatments now available for some cancers and rare diseases. But bringing such living medicines to more patients presents both scientific and financial challenges ...

For years, chimeric antigen receptor (CAR) T cell therapies have led the way in cell-based immunotherapy, offering hope to many patients with certain blood cancers. But now, researchers believe the ...

Chimeric antigen receptor (CAR-T) therapies have shown promise in targeting difficult-to-treat cancers; however, predicting the efficacy, durability, and response of these therapies remains a ...

When bones break and there is extreme tissue loss--such as after a car accident or a battlefield injury--current treatments don't often lead to effective healing. But certain stem cells from skeletal ...

LA JOLLA, CA—We owe a lot to tissue resident memory T cells (T RM). These specialized immune cells are among the body's first responders to disease. Rather than coursing through the bloodstream—as ...